Development of Evidence Based Indicators for The Detection of Drug Related Problems and Their Pharmacoeconomic Impact on Ovarian Cancer Patients

dc.contributor.guide	Uday Venkat Mateti
dc.coverage.spatial
dc.creator.researcher	Kala Bahadur Rawal
dc.date.accessioned	2025-04-16T06:24:55Z
dc.date.available	2025-04-16T06:24:55Z
dc.date.awarded	2024
dc.date.completed	2024
dc.date.registered	2021
dc.description.abstract	newline
dc.description.note
dc.format.accompanyingmaterial	None
dc.format.dimensions
dc.format.extent
dc.identifier.researcherid	0000-0002-7376-8550
dc.identifier.uri	http://hdl.handle.net/10603/633644
dc.language	English
dc.publisher.institution	NGSM Institute of Pharmaceutical Sciences
dc.publisher.place	Mangalore
dc.publisher.university	Nitte University
dc.relation
dc.rights	university
dc.source.university	University
dc.subject.keyword	Clinical Pre Clinical and Health
dc.subject.keyword	Evidence Based, Indicators ,Detection,Drug Related Problems
dc.subject.keyword	Pharmacoeconomic Impact ,Ovarian Cancer Patients
dc.title	Development of Evidence Based Indicators for The Detection of Drug Related Problems and Their Pharmacoeconomic Impact on Ovarian Cancer Patients
dc.title.alternative
dc.type.degree	Ph.D.